- $8.20bn
- $7.31bn
- $937.46m
- 88
- 15
- 74
- 62
Annual income statement for Klaviyo, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 291 | 473 | 698 | 937 |
| Cost of Revenue | ||||
| Gross Profit | 206 | 345 | 521 | 716 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 370 | 528 | 1,029 | 1,022 |
| Operating Profit | -79.2 | -55 | -331 | -84.1 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -79.1 | -49.1 | -307 | -43.7 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -79.4 | -49.2 | -308 | -46.1 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -79.4 | -49.2 | -308 | -46.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -79.4 | -49.2 | -308 | -46.1 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.315 | -0.195 | -1.17 | -0.173 |
| Dividends per Share |